185 related articles for article (PubMed ID: 21751202)
1. Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts.
Liu W; Choueiri TK; Cho E
Cancer; 2012 Feb; 118(3):797-803. PubMed ID: 21751202
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes.
Michalek IM; Graff RE; Sanchez A; Choueiri TK; Cho E; Preston MA; Wilson KM
Acta Oncol; 2023 Sep; 62(9):988-993. PubMed ID: 37482537
[No Abstract] [Full Text] [Related]
3. Statin use and the risk of renal cell carcinoma: national cohort study.
Chou YC; Lin CH; Wong CS; Chou WY; Chang JY; Sun CA
J Investig Med; 2020 Mar; 68(3):776-781. PubMed ID: 31822508
[TBL] [Abstract][Full Text] [Related]
4. Long-term Use of Statins and Risk of Renal Cell Carcinoma: A Population-based Case-Control Study.
Pottegård A; Clark P; Friis S; Hallas J; Lund L
Eur Urol; 2016 May; 69(5):877-82. PubMed ID: 26603781
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of analgesic use and risk of renal cell cancer.
Cho E; Curhan G; Hankinson SE; Kantoff P; Atkins MB; Stampfer M; Choueiri TK
Arch Intern Med; 2011 Sep; 171(16):1487-93. PubMed ID: 21911634
[TBL] [Abstract][Full Text] [Related]
6. Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma.
Kang JH; Boumenna T; Stein JD; Khawaja A; Rosner BA; Wiggs JL; Pasquale LR
JAMA Ophthalmol; 2019 Jul; 137(7):756-765. PubMed ID: 31046067
[TBL] [Abstract][Full Text] [Related]
7. Dietary Acrylamide Intake and Risk of Renal Cell Carcinoma in Two Large Prospective Cohorts.
Graff RE; Cho E; Preston MA; Sanchez A; Mucci LA; Wilson KM
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):979-982. PubMed ID: 29760239
[No Abstract] [Full Text] [Related]
8. Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies.
Graff RE; Sanchez A; Tobias DK; Rodríguez D; Barrisford GW; Blute ML; Li Y; Sun Q; Preston MA; Wilson KM; Cho E
Diabetes Care; 2018 Jul; 41(7):1432-1437. PubMed ID: 29678810
[TBL] [Abstract][Full Text] [Related]
9. Statin use and pancreatic cancer risk in two prospective cohort studies.
Hamada T; Khalaf N; Yuan C; Babic A; Morales-Oyarvide V; Qian ZR; Nowak JA; Ng K; Kraft P; Rubinson DA; Stampfer MJ; Giovannucci EL; Fuchs CS; Ogino S; Wolpin BM
J Gastroenterol; 2018 Aug; 53(8):959-966. PubMed ID: 29362938
[TBL] [Abstract][Full Text] [Related]
10. Statin Use and Breast Cancer Risk in the Nurses' Health Study.
Borgquist S; Tamimi RM; Chen WY; Garber JE; Eliassen AH; Ahern TP
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):201-6. PubMed ID: 26762806
[TBL] [Abstract][Full Text] [Related]
11. ABO blood group and risk of renal cell cancer.
Joh HK; Cho E; Choueiri TK
Cancer Epidemiol; 2012 Dec; 36(6):528-32. PubMed ID: 22841339
[TBL] [Abstract][Full Text] [Related]
12. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
13. Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
Santoni M; Monteiro FSM; Massari F; Abahssain H; Aurilio G; Molina-Cerrillo J; Myint ZW; Zabalza IO; Battelli N; Grande E
Crit Rev Oncol Hematol; 2022 Aug; 176():103731. PubMed ID: 35718065
[TBL] [Abstract][Full Text] [Related]
14. Statin utilization improves oncologic and survival outcomes in patients with dyslipidemia and surgically treated renal cell carcinoma.
Berquist SW; Lee HJ; Hamilton Z; Bagrodia A; Hassan AE; Beksaç AT; Dufour CA; Wang S; Mehrazin R; Patterson A; Derweesh IH
Minerva Urol Nefrol; 2017 Oct; 69(5):501-508. PubMed ID: 28376607
[TBL] [Abstract][Full Text] [Related]
15. Statins and survival outcomes in patients with metastatic renal cell carcinoma.
McKay RR; Lin X; Albiges L; Fay AP; Kaymakcalan MD; Mickey SS; Ghoroghchian PP; Bhatt RS; Kaffenberger SD; Simantov R; Choueiri TK; Heng DY
Eur J Cancer; 2016 Jan; 52():155-62. PubMed ID: 26687834
[TBL] [Abstract][Full Text] [Related]
16. Statin use and the risk of cholecystectomy in women.
Tsai CJ; Leitzmann MF; Willett WC; Giovannucci EL
Gastroenterology; 2009 May; 136(5):1593-600. PubMed ID: 19208351
[TBL] [Abstract][Full Text] [Related]
17. Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort.
Lee SE; Sung JM; Cho IJ; Kim HC; Chang HJ
PLoS One; 2018; 13(4):e0195459. PubMed ID: 29630642
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Statin Use, Total Cholesterol Level, and Risk of Colorectal Cancer: A Prospective Cohort Study.
Zhang Y; Wu K; Chan AT; Meyerhardt JA; Giovannucci EL
Am J Gastroenterol; 2022 Jan; 117(1):158-166. PubMed ID: 34730560
[TBL] [Abstract][Full Text] [Related]
19. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
20. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women.
Bjørge T; Tretli S; Engeland A
Am J Epidemiol; 2004 Dec; 160(12):1168-76. PubMed ID: 15583369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
